It is time for cheaper, faster, more granular, and more precise clinical trials Discovering new drugs, repurposing or repositioning existing ones, and reducing healthcare costs require cheaper, faster, more granular, and more precise clinical trials without compromising safety. While advances in digital technology hold promise, life science organizations are contingent on rethinking research designs in light of new patient-centric characteristics. Why Adaptive Design Resizing the sample, discontinuing treatments or doses, adjusting the ratio of patients to study arms, focusing recruitment efforts on patients most likely to benefit, and stopping the trial early for success or lack of efficacy. All of these adjustments…...
Supply Chain Planning and Clinical Trials Adaptive Design
2 min read